Divi’s Labs Q2FY25 Results: Net Profit Surges 46% to Rs 510 Crore
Divi’s Laboratories, a leading Indian pharmaceutical company, reported its financial results for the second quarter of fiscal year 2024-25 (Q2FY25), reflecting strong performance across key business segments, with notable increases in profit, revenue, and EBITDA. Divi’s Labs Q2FY25 Results Net Profit: Divi’s Labs reported a net profit of Rs 510 crore, marking a 46.5% increase … Read more